本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

158.14
-0.9900-0.62%
盘后158.140.00000.00%19:14 EDT
成交量:43.28万
成交额:6,866.43万
市值:95.08亿
市盈率:-23.39
高:161.87
开:161.50
低:155.96
收:159.13
数据加载中...
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities